Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1988 | 12-1987 | 09-1987 | 06-1987 | 03-1987 | |
Sales | 1,072,100 | 609,500 | 957,700 | 1,017,600 | 1,059,000 |
Cost of Goods | 353,100 | 235,400 | 333,300 | 362,600 | 371,500 |
Gross Profit | 719,000 | 374,100 | 624,400 | 655,000 | 687,500 |
Operating Expenses | 393,800 | 538,900 | 404,600 | 422,900 | 392,700 |
Operating Income | 325,300 | -164,400 | 220,100 | 232,700 | 295,300 |
Interest Expense | 0 | -44,800 | 14,900 | 16,300 | 13,600 |
Other Income | 15,200 | -39,900 | 18,800 | 7,900 | 24,500 |
Pre-tax Income | 340,500 | -159,500 | 224,000 | 224,300 | 306,200 |
Income Tax | 107,300 | -64,500 | 74,000 | 74,000 | 101,000 |
Net Income Continuous | 233,200 | -95,000 | 150,000 | 150,300 | 205,200 |
Net Income Discontinuous | 0 | 233,200 | 0 | 0 | 0 |
Net Income | $233,200 | $138,200 | $150,000 | $150,300 | $205,200 |
EBITDA(a) | $325,300 | $-164,400 | $220,100 | $232,700 | $295,300 |